Euglena Co Ltd (2931 JP): Q1 FY12/26 flash update
Sales increased to JPY13.2bn (+10.6% YoY), driven by Saticine Medical group orders and Q’sai group's direct sales performance. Adjusted EBITDA...
90 Views
Euglena Co Ltd (2931 JP): Q3 FY12/25 flash update
The company's adjusted EBITDA rose to JPY5.5bn (+68.1% YoY) due to improved profitability and reduced expenses. Segment sales in the Healthcare...
192 Views
Euglena Co Ltd (2931 JP): Q1 FY12/25 flash update
In Q1 FY12/25, sales reached JPY11.9bn (+7.0% YoY) with adjusted EBITDA at JPY1.5bn (+44.3% YoY). Segment sales in Healthcare were JPY10.9bn...
267 Views
Euglena Co Ltd (2931 JP): Q3 FY12/24 flash update
Adjusted EBITDA increased by 64.1% YoY to JPY3.2bn, with sales reaching JPY35.3bn, a 3.5% YoY growth. Biofuels segment sales declined by 65.4% YoY...
267 Views
Euglena Co Ltd (2931 JP): 1H FY12/24 flash update
Sales increased to JPY23.6bn (+3.7% YoY), operating profit reached JPY348mn, recurring profit JPY309mn, and net loss JPY267mn. Biofuels segment...
219 Views